G1 Therapeutics (United States)

Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension

Ronald J. Raymond, Alan L. Hinderliter, Park W. Willis et al. · Journal of the American College of Cardiology · 2002 · 819 citations

Hypertension, Pulmonary Arterial Hypertension, Primary Pulmonary Hypertension +7

Rho Family GTPase Modification and Dependence on CAAX Motif-signaled Posttranslational Modification

Patrick J. Roberts, Natalia Mitin, Patricia J. Keller et al. · Journal of Biological Chemistry · 2008 · 341 citations · Full text

Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo

Christopher C. Nixon, Maud Mavigner, Gavin C. Sampey et al. · Nature · 2020 · 311 citations · Full text

Viral Persistence, Human Retrovirus, Immunodeficiencies +14

Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector

Joshua C. Grieger, Stephen Soltys, R. Jude Samulski · Molecular Therapy · 2015 · 297 citations · Full text

Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension

Alan L. Hinderliter, Park W. Willis, Walker Long et al. · The American Journal of Cardiology · 1999 · 164 citations

Hypertension, Pulmonary Arterial Hypertension, Pulmonary Circulation +12